EcoDrugPlus


Synonyms	(s)-phenylmethylaminopropane J6.362B Metamfetamine Methamphetamine NSC-25115
Status
Molecule Category	Free-form
UNII	44RAL3456C
EPA CompTox	DTXSID8037128

Synonyms

(s)-phenylmethylaminopropane

J6.362B

Metamfetamine

Methamphetamine

NSC-25115

Status

Molecule Category

Free-form

UNII

44RAL3456C

EPA CompTox

DTXSID8037128


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	MYWUZJCMWCOHBA-VIFPVBQESA-N
Smiles	CN[C@@H](C)Cc1ccccc1
InChI	InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1

InChI Key

MYWUZJCMWCOHBA-VIFPVBQESA-N

Smiles

CN[C@@H](C)Cc1ccccc1

InChI

InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1

Countries
Croatia
Czech Republic
Germany
Hungary
Romania
Slovakia
Slovenia

Countries

Croatia

Czech Republic

Germany

Hungary

Romania

Slovakia

Slovenia

Resources	Reference
ChEBI	6809
ChEMBL	CHEMBL1201201
DrugBank	DB01577
DrugCentral	1732
FDA SRS	44RAL3456C
Human Metabolome Database	HMDB0015517
Guide to Pharmacology	4803
KEGG	C07164
PDB	B40
PharmGKB	PA450403
PubChem	10836
SureChEMBL	SCHEMBL42615
ZINC	ZINC000006021043

Resources

Reference

ChEBI

ChEMBL

DrugBank

DrugCentral

FDA SRS

Human Metabolome Database

HMDB0015517

Guide to Pharmacology

KEGG

PDB

PharmGKB

PubChem

SureChEMBL

ZINC


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

METHAMPHETAMINE

Structure

Environmental Exposure

Cross References